Ixensor Co

Ixensor Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Ixensor Co (6734.TWO) as of Nov 5, 2026 is -7.61. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -7.77 — a change of -1.96% (higher).

EV/EBITDA

-7.61

YoY

-1.96%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Ixensor Co is 2025 -7.61 . EV/EBITDA (Enterprise Value to EBITDA) of Ixensor Co was 2024 -7.77 . It decreases by -1.96% higher compared to the previous year.

The Ixensor Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
-1.33 TWD
Jan 1, 2019
-2.31 TWD
Jan 1, 2020
-3.79 TWD
Jan 1, 2021
-3.98 TWD
Jan 1, 2022
-58.66 TWD
Jan 1, 2023
-5.42 TWD
Jan 1, 2024
-7.77 TWD
Jan 1, 2025
-7.61 TWD
The Ixensor Co EV/EBITDA history
YEAREV/EBITDAYoY
-7.61-1.96%
-7.77+43.34%
-5.42-90.76%
-58.66+1,373.93%
-3.98+4.98%
-3.79+64.15%
-2.31+73.47%
-1.33-44.01%
-2.38+12.75%
-2.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ixensor Co Stock analysis

What does Ixensor Co do? iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring. Ixensor Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ixensor Co stock

EV/EBITDA (Enterprise Value to EBITDA) of Ixensor Co is -7.61 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Ixensor Co changed from -7.77 to -7.61, representing a -1.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Ixensor Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Ixensor Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ixensor Co

All Key Metrics — Ixensor Co